Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer

INTRODUCTION: It is unclear how soon after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection it is safe to resume systemic anti-neoplastic treatment in patients with cancer. We assessed the risk of admissions or postponed treatment cycle in vaccinated patients with breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Halpern, Naama, Boursi, Ben, Shacham-Shmueli, Einat, Gal-Yam, Einav Nili, Margalit, Ofer, Golan, Talia, Beller, Tamar, Strauss, Gal, Yahav, Dafna, Leshem, Eyal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673789/
https://www.ncbi.nlm.nih.gov/pubmed/37864026
http://dx.doi.org/10.1007/s40487-023-00247-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673789/
https://www.ncbi.nlm.nih.gov/pubmed/37864026
http://dx.doi.org/10.1007/s40487-023-00247-2

Ejemplares similares